Dr. Violaine Harris's and Dr. Saud Sadiq's research on fetuin-A as a CSF biomarker for active MS has been featured on the cover of this month’s issue of the Multiple Sclerosis Journal! This important biomarker discovery is based on spinal fluid measurement of Fetuin-A levels obtained over the course of several years of clinical and pathological studies of MS patients as well as experimental models of the disease.  Our findings are likely to change the process for making treatment decisions in MS patients.  Please visit www.tischms.org for more details on this exciting research and to request a copy of the publication.